Financial Performance - Revenue for the year ended December 31, 2023, was audited and reported in the annual results announcement[1] - Total revenue decreased by 24.7% to RMB 4,673.6 million in 2023 compared to RMB 6,205.1 million in 2022[16][17] - F-end strategic business revenue increased by 14.8% to RMB 2,204.7 million in 2023, while B-end strategic business revenue surged by 81.2% to RMB 1,078.5 million[17] - Gross profit margin improved by 5.4 percentage points to 32.3% in 2023, up from 26.9% in 2022[17] - Net loss narrowed significantly to RMB 334.9 million in 2023, a decrease of RMB 304.7 million compared to RMB 639.6 million in 2022[17] - Adjusted net loss for 2023 was RMB 315.1 million, a reduction of RMB 561.6 million compared to 2022[51] - Total available funds as of December 31, 2023, amounted to RMB 12,627.9 million, including cash and cash equivalents of RMB 1,866.5 million, restricted funds of RMB 84.8 million, time deposits of RMB 5,345.9 million, and financial assets of RMB 5,330.7 million[53] - Net cash used in operating activities for 2023 was RMB 282.9 million, a significant improvement compared to RMB 810.6 million in 2022[53] - Net cash used in investing activities for 2023 was RMB 1,486.1 million, primarily due to the purchase of financial products and time deposits amounting to RMB 11,398.4 million[53] - Capital expenditures for 2023 were RMB 42.96 million, mainly for the purchase of property, plant, and equipment, as well as intangible assets[55] - The company's asset-liability ratio was 19.69% as of December 31, 2023, calculated by dividing total liabilities by total assets[94] - Total loss of the Group's operating entities for the year ended December 31, 2023, was approximately RMB 129.5 million[160] - Total assets of the Group's operating entities as of December 31, 2023, were approximately RMB 12,268.2 million[160] Strategic Focus and Business Model - The company's strategic focus in 2023 was on deepening the integration with Ping An Group's "Comprehensive Finance + Healthcare and Elderly Care" strategy[9] - The company continued to focus on Ping An Group's comprehensive financial users and corporate clients, enhancing the breadth and depth of "Comprehensive Finance + Healthcare and Elderly Care" services[10] - The company aims to become a Chinese version of managed care model, focusing on serving financial and enterprise clients as its core customer groups[12] - The company links online/offline medical health and elderly care service resources, providing users with high-quality service experiences through family doctors and elderly care managers[13] - The company integrates medical health and elderly care service rights with financial/insurance product scenarios to provide users with full lifecycle medical health and elderly care services[13] - The company provides professional, comprehensive, high-quality, and one-stop enterprise health management services to enterprise clients, helping to improve employee health and reduce corporate healthcare costs[14] - The company deepened its managed care strategy by integrating medical, health, and elderly care services with Ping An Group's comprehensive financial business[22][23] - The company plans to deepen its managed care strategy, focusing on strategic business resources and leveraging the advantages of the Ping An Group in both F-end (commercial insurance/finance) and B-end (enterprise clients)[38] - The company will further optimize operational processes, deepen digital and AI empowerment, and promote resource optimization and organizational efficiency improvement[38] Organizational Restructuring and Management - The company has undergone a comprehensive organizational restructuring in 2023, adjusting multiple business units into five major centers: Sales Center, Medical Center, Product Center, Technology & Operations Center, and Shared Resources Center[12] - Li Dou was appointed as an executive director, Chairman of the Board, CEO, and authorized representative on October 18, 2023[121] - Fang Weihao resigned as Chairman of the Board, executive director, and CEO on October 18, 2023 due to personal work arrangements[121] - Wu Jun was appointed as an executive director on March 13, 2023[121] - The company's board consists of nine members, including one chairman, two executive directors, four non-executive directors, and three independent non-executive directors[190] - The company has adopted the Code on Corporate Governance Practices as its own corporate governance code[187] - The company has established mechanisms to ensure the board receives independent views and opinions, including regular reviews of relevant mechanisms[194] - The company's chairman, Mr. Li Dou, also serves as the CEO, a deviation from the Code on Corporate Governance Practices, which recommends separating the roles[192] - The company has no intention to separate the roles of chairman and CEO at present[193] - The company's board regularly reviews and monitors corporate governance practices to ensure compliance with the Code on Corporate Governance Practices[188] - The company's corporate governance principles emphasize effective internal controls, high ethical standards, transparency, accountability, and integrity[187] - The company's board believes that good corporate governance is essential for protecting shareholder interests, enhancing corporate value, and formulating business strategies and policies[187] - The company has appointed at least three independent non-executive directors, constituting at least one-third of the board, with one having appropriate professional qualifications in accounting or financial management[195] - Independent non-executive directors have confirmed their independence in accordance with Listing Rule 3.13, and the company considers them independent during the reporting period[196] - Non-executive directors, including independent non-executive directors, have a designated term of three years, subject to the Articles of Association and Listing Rules[197] - One-third of the directors must retire by rotation at each annual general meeting, with retiring directors eligible for re-election[197] - The board is responsible for the company's management, strategy formulation, and oversight of operational and financial performance[198] - The board has established three committees: Audit and Risk Management Committee, Nomination and Remuneration Committee, and Sustainability Committee, each with clearly defined terms of reference[199] - The Audit and Risk Management Committee is responsible for reviewing and supervising the group's financial reporting procedures and internal control systems[200] - The Audit and Risk Management Committee consists of two independent non-executive directors and one non-executive director, with Mr. Tang Yunwei as the chairman[200] Healthcare and Elderly Care Services - The AI health manager developed by the company has been applied in the "Million Chronic Disease Project" of Ping An Group, improving chronic disease management efficiency by up to 5 times[11] - As of the end of September 2023, the "Insurance + Home-based Elderly Care" model has covered 54 cities across the country[11] - The home-based elderly care service covers 54 cities nationwide, with an ARPU of nearly 1,600 yuan as of the end of the reporting period[24] - The family doctor membership covers nearly 13 million people, with an annual average usage frequency of 3 times, an increase of 0.8 times compared to the same period last year[32] - The active service coverage rate of family doctor members is nearly 75%[32] - The company has established a "three-in-one" elderly care butler system, linking over 500 home-based elderly care services[32] - The company has established a team of approximately 50,000 internal and external doctors covering 29 departments, with nearly 2,500 renowned medical experts signed, meeting users' full-scenario and multi-level medical health and elderly care service needs[33] - The company has built 23 specialized disease centers around 8 major specialties, providing standardized pre-diagnosis, diagnosis, and post-diagnosis solutions, with a user consultation five-star rating exceeding 98%[33] - The company has partnered with nearly 4,000 hospitals and 230,000 pharmacies, achieving 1-hour drug delivery in 271 cities[34] - The company has collaborated with over 103,000 health service providers and more than 2,000 health check-up providers, covering various health categories and service forms[34] - The company's medical AI technology covers approximately 36,000 diseases and 15 million questions, achieving 100% AI empowerment in all service links[35] - The company has obtained multiple international certifications including ISO27001, ISO27701, and ISO27799, demonstrating high-level information security management capabilities[35] Enterprise Health Management - The company provides professional, comprehensive, high-quality, and one-stop enterprise health management services to enterprise clients, helping to improve employee health and reduce corporate healthcare costs[14] - The number of "Physical Examination+" enterprise customers served reached 895, a cumulative year-on-year increase of 53.3%, and "Health Management+" enterprise customers reached 696, a cumulative year-on-year increase of 49.7%[29] - The company aims to leverage its advantages in commercial insurance and enterprise client resources, with the potential market size for enterprise health management estimated at 2-3 trillion yuan[37] User and Customer Metrics - LTM paying users for strategic business increased by 10.7% to 32 million in 2023, with F-end strategic business paying users growing by 6.7% to 26 million and B-end strategic business paying users surging by 75.0% to 5 million[18][19] - B-end cumulative served enterprises increased by 54.2% to 1,508 in 2023 compared to 978 in 2022[18][19] - The number of paying users served in the past 12 months was approximately 40 million as of December 31, 2023, a decrease of 7.3% compared to the same period in 2022[100] - The company served 1,508 enterprise clients, with over 5.1 million paying users in the B2B strategic business and approximately 26.3 million paying users in the F2B strategic business[100] - The top five customers accounted for approximately 27% of the company's total revenue, with the largest customer contributing about 10%[102] - The top five suppliers accounted for approximately 18% of the company's total costs, with the largest supplier contributing about 6%[102] Expenses and Cost Management - Management expenses decreased by 15.3% to RMB 1,480.9 million, and sales expenses dropped by 25.4% to RMB 835.8 million in 2023[17] - R&D expenses decreased by 18.1% to RMB 537.4 million in 2023[16] - Sales and marketing expenses decreased by 25.4% to RMB 835.8 million in 2023[45] - Administrative expenses decreased by 15.3% to RMB 1,480.9 million in 2023[46] - Other income decreased by 35.2% to RMB 142.9 million in 2023[47] - Net other gains decreased by 64.1% to RMB 90.0 million in 2023[48] - Net financial income increased by 55.4% to RMB 243.1 million in 2023[49] Employee and Compensation Information - The company employed 1,753 employees as of December 31, 2023, with a competitive compensation system including salary, discretionary bonuses, and benefits[62] - The company had 1,753 employees as of December 31, 2023, with stable employee relations and no significant labor disputes[99] - The company had 26,627,312 shares remaining available for issuance under the Employee Incentive Scheme (EIS) as of December 31, 2023, representing 2.38% of the issued shares[108] - The total number of unexercised EIS options as of December 31, 2023, was 11,651,148 shares[108] - The Employee Incentive Scheme is valid for 10 years from December 26, 2014, to December 25, 2024, with approximately 1 year remaining[110] - 300,000 shares were granted to Li Hongsheng, Chairman and CEO, on December 1, 2023, with a vesting period from December 1, 2024, to December 1, 2027[115] - 300,000 shares granted to Fang Weihao, former Executive Director and CEO, on January 11, 2021, with 153,345 shares remaining unexercised as of December 31, 2023[115] - 300,000 shares granted to Wu Jun, Executive Director and President, on October 26, 2021, with 228,345 shares remaining unexercised as of December 31, 2023[115] - 490,000 shares granted to the top five highest-paid individuals on October 23, 2022, with 422,500 shares remaining unexercised as of December 31, 2023[115] - 11,534,500 shares granted to other grantees on October 1, 2015, with 57,674 shares remaining unexercised as of December 31, 2023[117] - 16,475,800 shares granted to other grantees on March 31, 2017, with 875,979 shares remaining unexercised as of December 31, 2023[117] - 5,512,000 shares granted to other grantees on December 19, 2022, with 4,126,750 shares remaining unexercised as of December 31, 2023[119] - Total shares granted under the Employee Incentive Scheme (EIS) amounted to 73,331,415 shares, with 11,651,148 shares remaining unexercised as of December 31, 2023[119] - The fair value of EIS options granted on December 1, 2023, was based on the closing price of HKD 17.46 per share[120] - The weighted average closing price before the exercise of EIS options was HKD 16.60 for directors, HKD 18.56 for the top five highest-paid individuals, and HKD 21.85 for other grantees[120] Shareholder and Equity Information - Li Dou holds 300,000 shares, representing approximately 0.03% of the total issued shares[131] - Wu Jun holds 328,345 shares, representing approximately 0.03% of the total issued shares[131] - An Xin holds 441,000,000 shares, representing approximately 39.41% of the total issued shares[133] - Anke Technology Limited holds 441,000,000 shares, representing approximately 39.41% of the total issued shares[133] - Hopson Development Holdings Limited holds 101,708,800 shares, representing approximately 9.09% of the total issued shares[133] - Sounda Properties Limited holds 101,708,800 shares, representing approximately 9.37% of the total issued shares[133] - Hopson Development holds interests in a total of 101,708,800 shares of the company[135] - Sounda Properties is deemed to hold 104,793,500 shares, including 101,708,800 shares indirectly through Hopson Development and 3,084,700 shares directly[135] - The company's public shareholding ratio is maintained at a minimum of 21.3% as per the exemption granted by the Hong Kong Stock Exchange[182] - As of December 31, 2023, Urumqi Guangfengqi holds a 30% equity stake in Ping An Health Internet[176] Contracts and Agreements - The annual cap for the product and service provision framework agreement with Ping An for the year ending December 31, 2023, was RMB 8,700.0 million, with actual transaction amount of approximately RMB 1,405.5 million[144] - The annual cap for the service procurement framework agreement with Ping An for the year ending December 31, 2023, was RMB 1,638.0 million, with actual transaction amount of approximately RMB 561.7 million[147] - The renewed product and service provision framework agreement with Ping An is effective from January 1, 2024, to December 31, 2026[145] - The renewed service procurement framework agreement with Ping An is effective from January 1, 2024, to December 31, 2026[149] - The company expects to pay a total rent of no more than RMB 95.0 million to Ping An and/or its associates under the property leasing framework agreement for the year ending December 31, 2023, with the actual transaction amount being approximately RMB 29.3 million[151] - The annual cap for the property leasing framework agreement is RMB 157.0 million for the year ending December 31, 2023, with the total value of the right-of-use assets recognized as approximately RMB 12.9 million as of December 31, 2023[151] - The company renewed the property leasing framework agreement on October 25, 2023, with the new agreement effective from January 1, 2024, to December 31, 2026, covering properties in Beijing, Shanghai, and Guangzhou[152] - The maximum daily balance of deposits placed with Ping An Bank by the company for the year ending December 31, 2023, is capped at RMB 10,000.0 million, with the actual maximum daily balance being approximately RMB 5,721.3 million[154] - The company's deposit interest income from Ping An Bank for the year ending December 31, 2023, is capped at RMB 320.0 million, with the actual transaction amount being approximately RMB 50.6 million[154] - The maximum daily balance of wealth management products purchased by the company from Ping An and/or its associates for the year ending December 31, 2023, is capped at RMB 10,000.0 million, with the actual maximum daily balance being approximately RMB 4,585.5 million[154] - The investment income paid by Ping An and/or its associates to the company for the year ending December 31, 2023, is capped at RMB 450.0 million, with the actual transaction amount being approximately RMB 143.2 million[154] - The company renewed the financial services framework agreement on October 25, 2023, with the new agreement effective from January 1, 2024, to December 31, 2026, covering deposit and wealth management services[156] - Ping An Health Internet entered into an exclusive business cooperation agreement with Kangjian on October 18, 2017, for business support, technical, and consulting services[163] - Kangjian has an irrevocable exclusive right to purchase all or any

平安健康醫療科技有限公司 PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED （於開曼群島註冊成立的有限公司） 2023 年中期報告 股份代號 :1833.HK PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED 平安健康醫療科技有限公司 股份代號 :1833.HK 此中期報告（「中期報告」）（英文及中文版）已於本公司網站www.pagd.net登載。凡選擇 以本公司網站瀏覽公司通訊（包括但不僅限於年度報告及（如適用）財務摘要報告、中期 報告及（如適用）中期摘要報告、會議通告、上市文件、通函及代表委任表格）以代替任 何或所有印刷本之股東，可於提出要求下獲免費發送中期報告印刷本。 股東可隨時書面通知香港證券登記處，郵寄地址為香港灣仔皇后大道東183號合和中心 17M樓，或通過電郵地址pagd.ecom@computershare.com.hk，要求更改所選擇收 取公司通訊的方式（收取印刷本或通過本公司網站以電子方式瀏覽）及語言版本（僅收取 英文版 ；或僅收取中文版 ；或同時收取中、英文版）。 目錄 | 公司資料 | ...

[0 -> 1] 大家早上好 [1 -> 5] 首先感谢大家参加平安健康医疗科技有限公司 [5 -> 8] 2023年中期业绩发布会 [8 -> 10] 我是本次业绩发布会的主持人 [10 -> 13] 平安健康投资者关系部负责人王亦菲 [13 -> 14] Ariel [15 -> 17] 首先请允许我为各位介绍一下 [17 -> 20] 参与本次业绩发布会的公司管理层 [21 -> 24] 他们是平安健康医疗科技有限公司 [24 -> 25] 董事会主席 [25 -> 27] 首席执行官方卫豪先生 [31 -> 35] 平安健康医疗科技有限公司总裁吴军先生 [38 -> 41] 平安健康医疗科技有限公司资深副总裁 [41 -> 44] 暨首席财务官赞洛琪女士 [47 -> 49] 本次会议将由两部分组成 [49 -> 52] 在第一部分中方卫豪先生将介绍公司 [52 -> 56] 2023年上半年的整体经营状况和业绩亮点 [56 -> 59] 之后吴军先生将为各位介绍公司 [59 -> 62] 在2023年上半年业务方面的成功实践 [63 -> 65] 最后赞洛琪女士将回顾公司 [65 -> 68] 在2 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不會就因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED 平安健康醫療科技有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1833） 截至2023年6月30日止六個月期間 未經審計中期業績公告 平安健康醫療科技有限公司（「本公司」）董事會（「董事會」）欣然公佈本公司及其 附屬公司（「本集團」）截至2023年6月30日止六個月期間未經審計中期業績公告。 本公告刊載本公司2023年中期報告（「中期報告」）全文，並符合香港聯合交易所有 限公司（「聯交所」）證券上市規則中有關中期業績初步公告附載的資料之要求。 本公司審計及風險管理委員會已審閱本集團截至2023年6月30日止之六個月期間 中期業績。 本公告將於聯交所網站 www.hkexnews.hk 及本公司網站 www.pagd.net 發佈。截至 2023年6月30日止六個月期間中期報告將適時於上述聯交所及 ...

Business Model and Strategy - Ping An Healthcare has established a sustainable development model focusing on "managed healthcare + family doctor membership + O2O healthcare services" to enhance user experience and shareholder value[10]. - The company has shifted its target audience from individual customers to financially capable corporate clients, aiming to provide comprehensive healthcare services[10]. - The strategic deepening involves expanding product offerings from "healthcare" to "healthcare + wellness" and integrating online and offline services[10]. - Ping An Healthcare aims to become a professional, comprehensive, high-quality, one-stop provider of "healthcare + wellness" management services, with family doctors as key connectors[10]. - The company is facing pressures of comprehensive restructuring in "channels, products, and services" but views this as essential for sustainable development and innovation[10]. - The company emphasizes a "management-style healthcare + family doctor membership system + O2O healthcare service" business model to provide comprehensive healthcare services[14]. Client and User Metrics - In 2022, the company served over 47,000 corporate clients, covering more than 20 million employees, and nearly 228 million individual financial clients as of September 30, 2022[11]. - The company reported a user consultation five-star satisfaction rate exceeding 98% by December 31, 2022[11]. - The number of LTM paying users reached 43 million as of December 31, 2022, representing a growth of 5.3% from 40 million as of June 30, 2022[16]. - The number of B-end cumulative service enterprises increased to 978, a growth of 30.6% from 749[16]. - The company achieved a high renewal rate of nearly 90% among existing large-scale enterprise clients during the reporting period[22]. - The penetration rate of paying users from the Ping An Group's comprehensive financial channel reached approximately 15% of 228 million personal financial users[19]. Financial Performance - The total revenue for the year ended December 31, 2022, was RMB 6,159.8 million, a decrease of 16.0% compared to RMB 7,334.2 million in 2021[15]. - The gross profit margin increased by 4.0 percentage points to 27.3% in 2022, up from 23.3% in 2021[15]. - The net loss for the year decreased by 60.3% to RMB 611.1 million, compared to RMB 1,539.4 million in 2021[15]. - The adjusted net loss for the year was RMB 848.2 million, a decrease of 40.1% from RMB 1,417.2 million in 2021[15]. - Medical services revenue reached RMB 2,547.1 million, up 2.0% from RMB 2,496.0 million in 2021, with a 25.1% increase in the second half of 2022[36]. - Health services revenue declined by 25.3% to RMB 3,612.7 million from RMB 4,838.2 million in 2021, but showed a 13.0% increase in the second half of 2022[38]. Operational Efficiency and Cost Management - The company is actively enhancing profitability through a combination of internal growth and external expansion strategies[12]. - The company focused on enterprise health management products, creating a product system that includes two core products and four customized products[11]. - Sales and marketing expenses for 2022 were RMB 1,105.4 million, a reduction of 37.1% from RMB 1,756.8 million in 2021[40]. - Management expenses decreased by 5.3% to RMB 1,748.4 million in 2022 from RMB 1,846.4 million in 2021, attributed to improved efficiency[41]. - The company has established a comprehensive supplier management quality control system, covering the entire supply chain from entry to exit[27]. Service Network and Partnerships - The company established a "three-to" service network, including "to line," "to store," and "to home/company," enhancing service quality and user experience[11]. - As of December 31, 2022, the company had partnered with over 100,000 offline medical health service institutions, further improving service capabilities[11]. - The company has developed a comprehensive health management solution for medium to large enterprises, focusing on those with sufficient budgets and strong willingness to pay[21]. - The company has built a team of over 49,000 internal and external doctors from 23 departments, maintaining a patient satisfaction rate of over 98%[26]. - The company partnered with over 5,000 hospitals and 224,000 pharmacies, achieving 1-hour delivery in 216 cities and 24/7 delivery in 88 cities as of December 31, 2022[27]. Corporate Governance and Compliance - The company has adopted the corporate governance code and believes it has complied with all applicable provisions during the reporting period, except for the separation of the roles of chairman and CEO[170]. - The board of directors consists of nine members, including two executive directors and three independent non-executive directors[172]. - The independent non-executive directors have confirmed their independence according to the listing rules, ensuring their objectivity during the reporting period[179]. - The company has established mechanisms to ensure the board receives independent views and opinions to promote steady development[175]. - The audit committee reviewed the consolidated financial statements as of December 31, 2022, and confirmed compliance with applicable accounting standards[163]. Employee Relations and Incentives - The group has established a compensation system that includes cash salary, benefits, and long-term incentives, with competitive remuneration based on market conditions and individual performance[57]. - The company’s total number of employees was 2,556 as of December 31, 2022[92]. - The employee incentive plan is effective from December 26, 2014, to December 25, 2024, with approximately 2 years remaining[102]. - The total number of stock options granted under the EIS plan during the year was 73,031,415 shares, with 17,889,932 shares exercised and 1,134,870 shares canceled or expired[112]. - The gender ratio of the company's employees as of December 31, 2022, was 43.9% male and 56.1% female, with ongoing efforts to improve female representation[192]. Social Responsibility and Community Engagement - The company is committed to social responsibility, supporting rural healthcare initiatives and organizing free consultation activities[12]. - The company made charitable donations of approximately RMB 5,000 during the year ending December 31, 2022, compared to RMB 250,000 in 2021[88]. Future Plans and Investments - The company plans to utilize the net proceeds of HKD 7,828 million for further development of its core business before December 31, 2030[78]. - The company has a remaining net amount of HKD 1,674.1 million for business expansion, expected to be used by December 31, 2024[76]. - The company completed acquisitions of 100% stakes in two subsidiaries for a total consideration of approximately RMB 8.08 million and USD 96.86 million in October 2022[56].

[0 -> 2] 大家早上好 [2 -> 5] 感谢各位参加平安健康医疗科技有限公司 [5 -> 8] 2022年年报业绩发布会 [8 -> 10] 我是本次业绩发布会的主持人 [10 -> 13] 平安健康投资者关系部负责人 [13 -> 15] 王以菲 Aria [15 -> 18] 首先请允许我为各位介绍一下 [18 -> 21] 参与本次业绩发布会的公司管理层 [21 -> 24] 他们是平安健康医疗科技有限公司 [24 -> 26] 董事会主席 [26 -> 33] 首席执行官方卫豪先生 [33 -> 42] 平安健康医疗科技有限公司总裁吴军先生 [42 -> 44] 平安健康医疗科技有限公司 [44 -> 48] 资深副总裁兼首席财务官 [48 -> 52] 赞洛琪女士 [52 -> 54] 本次会议将由两部分组成 [54 -> 55] 第一部分中 [55 -> 57] 方卫豪先生将为各位介绍 [57 -> 62] 公司2022年全年的整体经营状况和业绩亮点 [62 -> 65] 之后吴军先生将为各位介绍 [65 -> 69] 公司2022年在业务方面的成功案例实践 [69 -> 72] 最后赞洛 ...

Market Growth and Trends - In 2021, the internet healthcare service usage increased, with nearly 50% of respondents using these services more than the previous year, and over 90% willing to choose online consultations and appointments in the coming year[6]. - The Chinese internet healthcare market is projected to grow rapidly, reaching a scale of 15 trillion yuan by 2025, with penetration increasing from 4.3% in 2020 to 13.2%[6]. - The ongoing pandemic has heightened public health awareness, accelerating the trend towards online medical services[6]. Company Strategy and Positioning - The company aims to enhance social healthcare efficiency by linking quality resources and providing professional guidance to meet diverse user needs[2]. - The company integrates three major models: HMO, family doctor membership system, and O2O medical services, emphasizing user convenience and cost-effectiveness[2]. - The company is positioned as a leading internet healthcare platform in China, bridging the gap between supply and demand in the healthcare industry[2]. - The company’s value proposition focuses on providing healthcare services that save users time, money, and effort[2]. - The company is committed to supporting the "Healthy China 2030" vision by alleviating pressure on social medical resources and meeting individual health needs[10]. Financial Performance - Total revenue for 2021 reached RMB 7,334.2 million, a year-on-year increase of 6.8%, with a gross margin of 23.3%[12]. - The company reported a net loss of RMB 1,539.4 million, a 62.3% increase in losses compared to 2020[12]. - The health service revenue accounted for 68.8% of total revenue, amounting to RMB 5,046.1 million, with a growth rate of 6.3%[12]. - The GMV of the marketplace reached RMB 6,119.9 million, reflecting an 11.8% increase from the previous year[14]. - The company’s annual report is available on its website, providing transparency and accessibility to stakeholders[2]. User Engagement and Satisfaction - The number of registered users increased to 422.9 million, representing a growth of 13.4% compared to 2020[13]. - The cumulative consultation volume reached 1,269.5 million, up 26.4% year-on-year[13]. - Ping An Health achieved over 98% in both consultation and medical record quality ratings, indicating high service quality[8]. - Ping An Health's patient satisfaction gradually improved, with no major medical complaints or disputes reported throughout the year[8]. Compliance and Risk Management - The company completed the ISO 27001 information security management system annual review and obtained ISO 27701 privacy information management system certification during the reporting period[9]. - The company established a mixed internal control management mechanism for its physical medical institutions and pharmacies to ensure stable medical quality and prevent management risks[8]. - The company has established a comprehensive compliance management system to ensure adherence to legal regulations and internal standards, which is crucial for sustainable development[177]. - The company has implemented a clear compliance risk management structure to identify and track compliance risks and regulatory changes[178]. Corporate Governance - The board consists of eight members, including one executive director, four non-executive directors, and three independent non-executive directors[119]. - The company has adopted a corporate governance code and has complied with all applicable provisions, except for the separation of the roles of chairman and CEO[117]. - The audit and risk management committee reviews the effectiveness of the risk management and internal control systems annually[139]. - The company has established clear terms of reference for its committees, defining their powers and responsibilities[126]. Social Responsibility and Sustainability - Ping An Health actively contributed to social responsibility by donating medical supplies and services to impoverished areas, enhancing basic medical service levels[9]. - The company has implemented a poverty alleviation program, providing a "green channel" for related products and combining external donations to achieve targeted poverty alleviation[181]. - The report emphasizes the importance of stakeholder communication and sustainability practices, highlighting the company's commitment to economic, environmental, and social sustainability[167]. - The company has committed to continuous improvement in compliance culture through various training and awareness initiatives[178]. Innovation and Technology - The company has invested 100 million in research and development for new technologies, focusing on improving user experience and operational efficiency[51]. - The company launched an instant audio-video online consultation service in 2021, available 24/7 with a 60-second response time, allowing users to consult with doctors face-to-face[200]. - The company has implemented AI technology to improve online medical service efficiency, with 306 severe disease labels identified across various medical disciplines[199]. Employee Engagement and Development - The company organized over 1,000 training sessions for medical staff throughout the year, covering various aspects of medical regulations and management[8]. - The company has upgraded its employee training system to meet the growth needs of employees and enhance business development[175]. - The employee incentive plan allows for a total of 70 million shares to be granted, with 17,889,932 options unexercised as of December 31, 2021[70]. Future Outlook - The company has set a future outlook with a revenue guidance of 1.8 billion for the next fiscal year, indicating a projected growth of 20%[51]. - New product launches are expected to contribute an additional 200 million in revenue, driven by advancements in technology and user engagement[51]. - The company plans to continue promoting the family doctor membership model to meet high-quality medical health demands[22].

| --- | --- | --- | --- | --- | --- | --- | --- | |-------------------|------------------------------------------------------------------------------------------------------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | 平安健康醫療科技有限公司10101 | | | | | | | | | PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED 1010 (於開曼群島註冊成立的有限公司) \| 01000001101010101010101010 2021年中期報告 | | | | | | | | | | | | | | | | | 股份代號：1833.HK | | | | | | | | 南京長江大橋是第一座完全「中國製造」的雙層式公路、鐵 ...